Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 348

Similar articles for PubMed (Select 22151736)

1.

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.

Takamori A, Hasegawa A, Utsunomiya A, Maeda Y, Yamano Y, Masuda M, Shimizu Y, Tamai Y, Sasada A, Zeng N, Choi I, Uike N, Okamura J, Watanabe T, Masuda T, Kannagi M.

Retrovirology. 2011 Dec 7;8:100. doi: 10.1186/1742-4690-8-100.

2.

Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.

Kozako T, Arima N, Toji S, Masamoto I, Akimoto M, Hamada H, Che XF, Fujiwara H, Matsushita K, Tokunaga M, Haraguchi K, Uozumi K, Suzuki S, Takezaki T, Sonoda S.

J Immunol. 2006 Oct 15;177(8):5718-26.

3.

IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.

Best I, López G, Verdonck K, González E, Tipismana M, Gotuzzo E, Vanham G, Clark D.

Immunology. 2009 Sep;128(1 Suppl):e777-86. doi: 10.1111/j.1365-2567.2009.03082.x. Epub 2009 Feb 17.

4.

Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.

Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1705-9.

PMID:
11080814
6.

Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.

Manuel SL, Sehgal M, Connolly J, Makedonas G, Khan ZK, Gardner J, Betts MR, Jain P.

J Clin Immunol. 2013 Oct;33(7):1223-39. doi: 10.1007/s10875-013-9918-x. Epub 2013 Jul 26.

7.

Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR.

J Immunol. 2004 Feb 1;172(3):1735-43.

8.

Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.

Best I, López G, Talledo M, MacNamara A, Verdonck K, González E, Tipismana M, Asquith B, Gotuzzo E, Vanham G, Clark D.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1207-12. doi: 10.1089/AID.2011.0029. Epub 2011 May 9.

PMID:
21453202
9.

Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.

Shimizu Y, Takamori A, Utsunomiya A, Kurimura M, Yamano Y, Hishizawa M, Hasegawa A, Kondo F, Kurihara K, Harashima N, Watanabe T, Okamura J, Masuda T, Kannagi M.

Cancer Sci. 2009 Mar;100(3):481-9. doi: 10.1111/j.1349-7006.2008.01054.x. Epub 2008 Dec 16.

PMID:
19154412
10.

Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.

Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N.

Hum Immunol. 2011 Nov;72(11):1001-6. doi: 10.1016/j.humimm.2011.07.308. Epub 2011 Aug 2.

PMID:
21851845
11.

Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.

Kozako T, Akimoto M, Toji S, White Y, Suzuki S, Arima T, Suruga Y, Matsushita K, Shimeno H, Soeda S, Kubota R, Izumo S, Uozumi K, Arima N.

J Med Virol. 2011 Mar;83(3):501-9. doi: 10.1002/jmv.21985.

PMID:
21264872
12.

Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.

Saito M, Braud VM, Goon P, Hanon E, Taylor GP, Saito A, Eiraku N, Tanaka Y, Usuku K, Weber JN, Osame M, Bangham CR.

Blood. 2003 Jul 15;102(2):577-84. Epub 2003 Jan 30.

13.

Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.

Ureta-Vidal A, Pique C, Garcia Z, Dehée A, Tortevoye P, Désiré N, Gessain A, Chancerel B, Gout O, Lemonnier FA, Cochet M.

J Infect Dis. 2001 Mar 15;183(6):857-64. Epub 2001 Feb 13.

14.
15.

Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.

McGinn TM, Wei Q, Stallworth J, Fultz PN.

AIDS Res Hum Retroviruses. 2004 Apr;20(4):443-56.

PMID:
15157363
16.

Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.

Arnulf B, Thorel M, Poirot Y, Tamouza R, Boulanger E, Jaccard A, Oksenhendler E, Hermine O, Pique C.

Leukemia. 2004 Jan;18(1):126-32.

PMID:
14574331
18.

In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y.

Retrovirology. 2009 Feb 19;6:19. doi: 10.1186/1742-4690-6-19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk